Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy

Background— Enterovirus infection is a cause of cardiomyopathy. We previously demonstrated that enteroviral protease 2A directly cleaves the cytoskeletal protein dystrophin. However, the direct effect of protease 2A in enteroviral cardiomyopathy is less clear because other viral proteins are also expressed with viral infection. Methods and Results— A transgenic mouse with inducible cardiac-restricted expression of enteroviral protease 2A was generated. In the transgenic mouse, a tamoxifen-regulated Cre-loxP system, MerCreMer (MCM), was used to induce genetic recombination in cardiac myocytes, which led to protease 2A expression. Protease 2A and MCM double transgenic (2AxMCM) mice were treated with tamoxifen; the controls included 2AxMCM mice treated with diluents for tamoxifen and tamoxifen-treated MCM littermates. Protease 2A activity was significantly induced after tamoxifen in the 2AxMCM mice compared with controls. Echocardiographic analysis demonstrated an increase in left ventricular end-diastolic and end-systolic chamber size, with decreased fractional shortening in tamoxifen-treated 2AxMCM mice. There was an increase in heart weight-to-body weight ratio in 2AxMCM mice treated with tamoxifen. Only a small increase in interstitial fibrosis and inflammation was found in tamoxifen-treated 2AxMCM mice; however, ultrastructural analysis demonstrated myofibrillar collapse with abnormalities of intercalated discs and sarcolemmal membranes. Evans blue dye–positive myocytes with disruption of dystrophin were present in 2AxMCM mice treated with tamoxifen. Disruption of dystrophin was also found in cultured myocytes isolated from 2AxMCM mice with Cre in the nucleus. Conclusions— Protease 2A has a significant role in enteroviral cardiomyopathy and alone is sufficient to induce dilated cardiomyopathy, which is associated with disruption of the sarcolemmal membrane and cleavage of dystrophin with protease 2A expression.

[1]  M. Kozak.  A second look at cellular mRNA sequences said to function as internal ribosome entry sites , 2005, Nucleic acids research.

[2]  M. Kozak,et al.  Regulation of translation via mRNA structure in prokaryotes and eukaryotes. , 2005, Gene.

[3]  J. Ross,et al.  Dilated cardiomyopathy caused by tissue‐specific ablation of SC35 in the heart , 2004, The EMBO journal.

[4]  M. Weitzman,et al.  The suppressor of cytokine signaling-1 (SOCS1) is a novel therapeutic target for enterovirus-induced cardiac injury. , 2003, The Journal of clinical investigation.

[5]  C. Badorff,et al.  Dystrophin deficiency markedly increases enterovirus-induced cardiomyopathy: A genetic predisposition to viral heart disease , 2002, Nature Medicine.

[6]  M. Crackower,et al.  Temporally Regulated and Tissue-Specific Gene Manipulations in the Adult and Embryonic Heart Using a Tamoxifen-Inducible Cre Protein , 2001, Circulation research.

[7]  V. Racaniello.  Picornaviridae : the viruses and their replication , 2001 .

[8]  R. Rhoads,et al.  Nitric Oxide Inhibits Dystrophin Proteolysis by Coxsackieviral Protease 2A Through S-Nitrosylation: A Protective Mechanism Against Enteroviral Cardiomyopathy , 2000, Circulation.

[9]  C. Badorff,et al.  Dissociation of Sarcoglycans and the Dystrophin Carboxyl Terminus From the Sarcolemma in Enteroviral Cardiomyopathy , 2000, Circulation research.

[10]  J. Mosnier,et al.  Enteroviral capsid protein VP1 is present in myocardial tissues from some patients with myocarditis or dilated cardiomyopathy. , 2000, Circulation.

[11]  M. Martone,et al.  Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy , 1999, Nature Medicine.

[12]  N. Dalton,et al.  Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy. , 1998, The Journal of clinical investigation.

[13]  R. Kandolf,et al.  Low-level expression of a mutant coxsackieviral cDNA induces a myocytopathic effect in culture: an approach to the study of enteroviral persistence in cardiac myocytes. , 1998, Circulation.

[14]  Minoru Hongo,et al.  MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.

[15]  J. Ross,et al.  Transthoracic echocardiography in models of cardiac disease in the mouse. , 1996, Circulation.

[16]  R. Rueckert.  Picornaviridae: The viruses and their replication , 1996 .

[17]  J. Fewell,et al.  Transgenic remodeling of the contractile apparatus in the mammalian heart. , 1996, Circulation research.

[18]  M. Bovee,et al.  Defective RNA replication by poliovirus mutants deficient in 2A protease cleavage activity , 1995, Journal of virology.

[19]  T. Martino,et al.  Viral infection and the pathogenesis of dilated cardiomyopathy. , 1994, Circulation research.

[20]  R. Rhoads,et al.  Mapping the cleavage site in protein synthesis initiation factor eIF-4 gamma of the 2A proteases from human Coxsackievirus and rhinovirus. , 1993, The Journal of biological chemistry.

[21]  K. Klingel,et al.  Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation. , 1993, Intervirology.

[22]  K. Klingel,et al.  The role of enterovirus replication in the development of acute and chronic heart muscle disease in different immunocompetent mouse strains. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[23]  K. Klingel,et al.  Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[24]  N. Sonenberg,et al.  Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA , 1988, Nature.

[25]  M. Kozak,et al.  At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. , 1987, Journal of molecular biology.

[26]  H. Tazelaar,et al.  Leukocytic Infiltrates in Idiopathic Dilated Cardiomyopathy: A Source of Confusion with Active Myocarditis , 1986, The American journal of surgical pathology.

[27]  P. Hofschneider,et al.  Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. , 1985, Journal of molecular and cellular cardiology.

[28]  Woodruff Jf.  Viral myocarditis. A review. , 1980 .

[29]  J. Woodruff.  Viral myocarditis. A review. , 1980, The American journal of pathology.